個股熱度排行 | 2月17日港股收盤
根據uSMART輿情監測數據,17日港股交易時段,市場關注指數最高的3只股票是藥明生物、渣打集團、贛鋒鋰業。
2月17日—港股關注排行TOP3

藥明生物

關注度第一爲藥明生物,該股今日收盤上漲6.06%,報於64.80港元。近5個交易日累計上漲11.15%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:
藥明生物漲近5% 獲南下資金連續5日淨買入
恆指全日收報24,792點 升73點; 恆生科技指數全日收報5,662點 升45點 藥明生物升逾6% 亞信科技創新高 成交暢旺
渣打集團

關注度第二爲渣打集團,該股今日收盤下跌2.23%,報於57.05港元。近5個交易日累計下跌3.39%。在消息面和社交媒體方面,輿情以看空爲主。較被市場關注的消息有:
渣打去年業績遜預期 股價午後跌近3%
渣打集團2021年第四季度虧損減少20%至3.82億美元
贛鋒鋰業

關注度第三爲贛鋒鋰業,該股今日收盤上漲7.64%,報於135.30港元。近5個交易日累計上漲12.38%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:
贛鋒鋰業逆市續漲7%重越百天線 A股曾漲8.5%
港股鋰電池股持續走高 贛鋒鋰業漲7.8%
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.